TAYLOR MARTINUZZI: Open Payments
NPI 1144930041 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 33 payments from 8 companies in 2025. Trend: 2023 $785 · 2024 $945 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $210 |
| Lilly USA, LLC | 9 | $147 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Amgen Inc. | 3 | $48 |
| PFIZER INC. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: MOUNJARO, Wegovy, SPRAVATO, Rybelsus, EVENITY, ELIQUIS, CAPVAXIVE, OTEZLA.
Industry payments across TX — which companies pay providers there.
